Difference between revisions of "Team:Tuebingen"

Line 14: Line 14:
 
     <div class='contentBothCols'>
 
     <div class='contentBothCols'>
 
         <p>
 
         <p>
             Supper small summary about what we do here.
+
             Hereditary Fructose intolerance is a rare genetic disorder, caused by a deficiency in Aldolase-B, leading to liver or kidney failure after fructose uptake. We will genetically modify the probiotic Lactobacillus johnsonii to metabolize fructose and sucrose instead of glucose in order to effectively remove these metabolites. Therefore we will knock out enzymes involved in glucose metabolism and increase the uptake and metabolism of fructose and sucrose. In order to avoid a significant impact on growth rates we will select suitable knock-out targets based on an analysis of in silico models of closely related species. Since cloning is the main work in both our and most other iGEM projects, we want to make cloning faster, easier and cheaper. We will achieve this by creating backbone inserts for a new plasmid series, that will allow the use of negative selection and a novel plasmid purification technique with the iGEM 3A assembly.
 
         </p>
 
         </p>
 
     </div>
 
     </div>
 
</div>
 
</div>
 
</html>
 
</html>

Revision as of 12:10, 6 October 2016

Hereditary Fructose intolerance is a rare genetic disorder, caused by a deficiency in Aldolase-B, leading to liver or kidney failure after fructose uptake. We will genetically modify the probiotic Lactobacillus johnsonii to metabolize fructose and sucrose instead of glucose in order to effectively remove these metabolites. Therefore we will knock out enzymes involved in glucose metabolism and increase the uptake and metabolism of fructose and sucrose. In order to avoid a significant impact on growth rates we will select suitable knock-out targets based on an analysis of in silico models of closely related species. Since cloning is the main work in both our and most other iGEM projects, we want to make cloning faster, easier and cheaper. We will achieve this by creating backbone inserts for a new plasmid series, that will allow the use of negative selection and a novel plasmid purification technique with the iGEM 3A assembly.